evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
13373,GENE_SUMMARY,,"NKX2-1 encodes a transcription factor involved in lung, thyroid and ventral forebrain development. Mutations, amplifications, and rearrangements of NKX2-1 are found in lung, goiter and thyroid cancers and leukemias.",,2017-04-03,,7080,NKX2-1,NK2 homeobox 1,False,ENST00000354822,NM_001079668.2,NKX2A,BCH,NK-2,TEBP,TITF1,NKX2.1,BHC,NMTC1,TTF-1,T/EBP,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
13374,GENE_BACKGROUND,,"NKX2-1 (NKX homeobox-1 gene) is an homeobox-containing transcription factor essential for development of the lung and thyroid as well as ventral forebrain (PMID: 16405855). NKX2-1 expression has been found in a variety of tumor types, particularly in lung and thyroid cancers, in which the distribution is similar to that in normal tissues. In lung, NKX2-1 is expressed in around 70% of adenocarcinomas and 90% of small cell carcinomas, whereas it was not found or found at very low frequency in squamous carcinomas and large cell carcinomas. NKX2-1 has recently emerged as a useful molecular marker for lung cancer diagnosis (PMID: 23125078). In thyroid carcinomas NKX2-1 is primarily expressed in the follicular neoplasm and papillary carcinoma but not in anaplastic carcinoma (PMID: 12023581). In lung adenocarcinoma, sustained expression of NKX2-1 is frequently associated with gene amplification (PMID: 17925434, 18212743, 17616654, 17982442). A germline missense mutation of NKX2-1 that results in a valine substitution for alanine at codon 339 (A339V) has been identified in families affected by multinodular goiter and papillary thyroid carcinoma (PMID: 19176457). Rearrangements of NKX2-1 with T cell receptor or immunoglobulin heavy chain loci were also recently identified in T cell acute lymphoblastic leukemia (PMID: 21481790). Several lines of evidence suggest possible oncogenic involvement of NKX2-1 in other cancer types, such as gastrointestinal, genitourinary and neuroectodermal origin (glioblastoma and ependimoma) neoplasms (atlasgeneticoncology.com; 06/19/15). NKX2-1 appears to function as a double-edge sword in cancer pathogenesis. Despite its evident role as a an oncogene in lung adenocarcinomas, NKX2-1 expression is also associated with favorable prognosis, reducing invasion and metastasis in affected patients (PMID: 21471965).",,2017-04-03,,7080,NKX2-1,NK2 homeobox 1,False,ENST00000354822,NM_001079668.2,NKX2A,BCH,NK-2,TEBP,TITF1,NKX2.1,BHC,NMTC1,TTF-1,T/EBP,False,12023581,TTF-1 expression in pulmonary adenocarcinomas.,The American journal of surgical pathology,2018-06-01T20:02:00,26,6,767-73,Yatabe Y et al,,,0001-06-01,,21481790,Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.,Cancer cell,2018-04-12T20:11:00,19,4,484-97,Homminga I et al,doi: 10.1016/j.ccr.2011.02.008,,0001-04-12,,17616654,Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.,Cancer research,2018-07-01T20:07:00,67,13,6007-11,Tanaka H et al,,,0001-07-01,,21471965,Suppression of lung adenocarcinoma progression by Nkx2-1.,Nature,2018-05-05T20:11:00,473,7345,101-4,Winslow MM et al,doi: 10.1038/nature09881,,0001-05-05,,19176457,A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.,Journal of the National Cancer Institute,2018-02-04T20:09:00,101,3,162-75,Ngan ES et al,doi: 10.1093/jnci/djn471,,0001-02-04,,16405855,Regulation of organ development by the NKX-homeodomain factors: an NKX code.,"Cellular and molecular biology (Noisy-le-Grand, France)",2018-10-24T20:05:00,Suppl 51,,OL785-99,Stanfel MN et al,,,0001-10-24,,17925434,Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.,Proceedings of the National Academy of Sciences of the United States of America,2018-10-16T20:07:00,104,42,16663-8,Kendall J et al,,,0001-10-16,,17982442,Characterizing the cancer genome in lung adenocarcinoma.,Nature,2017-12-06T20:07:00,450,7171,893-8,Weir BA et al,,,0001-12-06,,23125078,Nkx2-1: a novel tumor biomarker of lung cancer.,Journal of Zhejiang University. Science. B,2018-11-01T20:12:00,13,11,855-66,Yang L et al,doi: 10.1631/jzus.B1100382,,0001-11-01,,18212743,Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.,Oncogene,2018-06-05T20:08:00,27,25,3635-40,Kwei KA et al,doi: 10.1038/sj.onc.1211012,,0001-06-05,
